Glycoproteinoses

[1]. Bryce A Heese, et al. Current strategies in the management of lysosomal storage diseases. Semin Pediatr Neurol. 2008 Sep;15(3):119-26. [Content Brief]

[2]. Chiung-Mei Chen, et al. First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study. J Neurol Sci. 2006 Aug 15;247(1):65-9. [Content Brief]

[3]. Claude Abdallah, et al. Anesthesia for fucosidosis. Paediatr Anaesth. 2007 Oct;17(10):994-7. [Content Brief]

[4]. Dag Malm, et al. Alpha-mannosidosis. Orphanet J Rare Dis. 2008 Jul 23;3:21. [Content Brief]

[5]. E Bonten, et al. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 1996 Dec 15;10(24):3156-69. [Content Brief]

[6]. Hitoshi Sakuraba, et al. Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease). J Hum Genet. 2004;49(1):1-8. [Content Brief]

[7]. I Mononen, et al. Aspartylglycosaminuria: protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation. FASEB J. 1993 Oct;7(13):1247-56. [Content Brief]

[8]. J C Michalski, et al. Glycoprotein lysosomal storage disorders: alpha- and beta-mannosidosis, fucosidosis and alpha-N-acetylgalactosaminidase deficiency. Biochim Biophys Acta. 1999 Oct 8;1455(2-3):69-84. [Content Brief]

[9]. Nathaniel E Clark, et al. The 1.9 a structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases. J Mol Biol. 2009 Oct 23;393(2):435-47. [Content Brief]

[10]. P J Willems, et al. Spectrum of mutations in fucosidosis. Eur J Hum Genet. 1999 Jan;7(1):60-7. [Content Brief]

[11]. Pierre Labauge, et al. Beta-mannosidosis: a new cause of spinocerebellar ataxia. Clin Neurol Neurosurg. 2009 Jan;111(1):109-10. [Content Brief]

[12]. Volkan Seyrantepe, et al. Molecular pathology of NEU1 gene in sialidosis. Hum Mutat. 2003 Nov;22(5):343-52. [Content Brief]